Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Society of Nephrology. Clinical Journal

• Publication date

  2013-07-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.2215/CJN.09440912PMID 23559679PMCID PMC3700693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence

  2012cited by this paper
• Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.

  2012cited by this paper
• Issues of Adherence to Immunosuppressant Therapy After Solid-Organ Transplantation

  2012cited by this paper
• Understanding the Causes of Kidney Transplant Failure : The Dominant Role of Antibody-Mediated Rejection and Nonadherence

  2011cited by this paper
• Drug coverage for transplantation turns into political football: big business trumps patients.

  2010cited by this paper
• Cost-related immunosuppressive medication nonadherence among kidney transplant recipients.

  2010cited by this paper
• US Health Care Reform and Transplantation. Part I: Overview and Impact on Access and Reimbursement in the Private Sector

  2010cited by this paper
• A conflict of responsibility: no patient left behind.

  2010cited by this paper
• Medicare from A to D: what every nephrologist needs to know.

  2008cited by this paper
• The financial impact of immunosuppressant expenses on new kidney transplant recipients *,†

  2008cited by this paper
• Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients

  2008cited by this paper
• A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients

  2005cited by this paper
• Cost‐Effectiveness of Extending Medicare Coverage of Immunosuppressive Medications to the Life of a Kidney Transplant

  2004cited by this paper
• Prescription noncompliance due to cost among adults with disabilities in the United States.

  2002cited by this paper
• The natural history of azathioprine compliance after renal transplantation.

  2001cited by this paper
• Effect of Extended Coverage of Immunosuppressive Medications by Medicare on the Survival of Cadaveric Renal Transplants

  2001cited by this paper
• A medical anthropologist's view on posttransplant compliance: the underground economy of medical survival.

  1999cited by this paper
• Nonadherence to immunosuppressive medications: a pilot survey of members of the transplant recipients international organization.

  1999cited by this paper
• Late renal allograft loss: noncompliance masquerading as chronic rejection.

  1999cited by this paper
• Organ transplantation as a transformative experience: anthropological insights into the restructuring of the self.

  1995cited by this paper
• INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS

  1995cited by this paper
• Tapering or discontinuing cyclosporine for financial reasons--a single-center experience.

  1993cited by this paper
• Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants.

  1988cited by this paper

• Assessment of Tacrolimus Adherence in Kidney Transplant Patients at Ahmed Gasim Hospital, Khartoum, Sudan (2022–2023)

  2025cites this paper
• Landscape of US Waitlist Registrants who Received Transplantation Abroad.

  2025cites this paper
• Disparities in Transplant Interventions.

  2023cites this paper
• The Relationship Between Change in Employment Status, Insurance Coverage, and Graft Failure or Death After Kidney Transplant

  2022cites this paper
• Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist

  2021cites this paper
• NUMBER NEEDED TO TREAT AS A TOOL FOR COST EFFECTIVENESS ANALYSIS: A CASE STUDY IN RENAL TRANSPLANTATION

  2020cites this paper
• Progressive improvement in short‐, medium‐ and long‐term graft survival in kidney transplantation patients in Ireland – a retrospective study

  2019cites this paper
• Medicare immunosuppressive drug coverage bills—Can we afford them?

  2019cites this paper
• The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes

  2019cites this paper
• Social deprivation is associated with poor kidney transplantation outcome in children.

  2019cites this paper
• Validation of the Living Kidney Donor Profile Index in a European cohort and comparison of long-term outcomes with US results.

  2019cites this paper
• Are Generic Immunosuppressive Drugs the Solution for Providing Lifelong Medication Coverage to Transplant Recipients?

  2019cites this paper
• Academic achievement and employment in young adults with end‐stage kidney disease

  2018cites this paper
• Systematic review: impact of liver transplantation on employment.

  2018cites this paper
• Identifying Barriers to Preemptive Kidney Transplantation in a Living Donor Transplant Cohort

  2018cites this paper
• The prevalence, risk factors, and outcomes of medication trade‐offs in kidney and liver transplant recipients: a pilot study

  2018cites this paper
• Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology

  2018cites this paper
• Modeling Kidney Transplantation Decisions: Regulatory Oversight, Information Sharing, and Post-Transplant Drug Choice

  2018cites this paper
• Would government compensation of living kidney donors exploit the poor? An empirical analysis

  2018cites this paper
• A Systematic Review of the Prevalence and Associations of Limited Health Literacy in CKD.

  2017cites this paper
• Closing the gap between evidence and practice in chronic kidney disease.

  2017cites this paper
• Racial differences in incident de novo donor‐specific anti‐HLA antibody among primary renal allograft recipients: results from a single center cohort study

  2017cites this paper
• Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States

  2017cites this paper
• Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients

  2016cites this paper
• Depression and Immunosuppressive Therapy Adherence Following Renal Transplantation in Military Healthcare System Beneficiaries

  2016cites this paper
• Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients

  2016cites this paper
• Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.

  2016cites this paper
• Different Effects of Tacrolimus on Innate and Adaptive Immune Cells in the Allograft Transplantation

  2016cites this paper
• Restoration of Thymus Function with Bioengineered Thymus Organoids

  2016cites this paper
• Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?

  2016cites this paper
• The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children

  2016cites this paper
• De Novo Donor‐Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis

  2016cites this paper
• Low-Dose RATG with or without Basiliximab in Renal Transplantation: A Matched-Cohort Observational Study

  2015cites this paper
• Low-Dose RATG with or without Basiliximab in Renal Transplantation: A Matched-Cohort Observational Study

  2015cites this paper
• A Cost‐Benefit Analysis of Government Compensation of Kidney Donors

  2015cites this paper
• Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance

  2013cites this paper